Skip Navigation


European Heart Journal Advance Access originally published online on October 2, 2006
European Heart Journal 2006 27(23):2846-2857; doi:10.1093/eurheartj/ehl272
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary Data
Right arrow All Versions of this Article:
27/23/2846    most recent
ehl272v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (19)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Burgess, D. C.
Right arrow Articles by Keech, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burgess, D. C.
Right arrow Articles by Keech, A. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis

David C. Burgess1,2,*, Michael J. Kilborn2 and Anthony C. Keech1,2,*

1 National Health and Medical Research Council Clinical Trials Centre, University of Sydney, Level 5, Building F, 88 Mallett Street, Camperdown 2050, Sydney, NSW, Australia
2 Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, Sydney, NSW, Australia

Received 6 February 2006; revised 21 July 2006; accepted 11 September 2006; online publish-ahead-of-print 2 October 2006.

* Corresponding authors. Tel: +61 2 9562 5000; fax: +61 2 9565 1863. E-mail address: startup{at}ctc.usyd.edu.au

See page 2744 for the editorial comment on this article (doi:10.1093/eurheartj/ehl372)

Aims Atrial fibrillation (AF) is the most common complication after cardiac surgery. We aimed to evaluate, by meta-analysis, all randomized trials testing interventions for preventing AF.

Methods and results Ninety-four trials of prevention of post-operative AF were identified, by standard search methods, and analysed by standard meta-analysis techniques. All five commonly tested interventions, beta-blockers (BBs), sotalol, amiodarone, magnesium, and atrial pacing, were effective in preventing AF. The odds ratio (OR) for the effect of BB on the incidence of AF was 0.36 (95% CI 0.28–0.47, P<0.001), but after trials confounded by post-operative non-study BB withdrawal were excluded was 0.69 (95% CI 0.54–0.87, P=0.002). Sotalol reduced AF, compared with placebo (OR 0.34, 95% CI 0.26–0.45, P<0.001) and compared with conventional BB (OR 0.42, 95% CI 0.26–0.65, P<0.001). Amiodarone reduced AF (OR 0.48, 95% CI 0.40–0.57, P<0.001). Magnesium (Mg) also had an effect (OR 0.57 95% CI 0.42–0.77) but there was significant heterogeneity (P<0.001), partly explained by concomitant BB. The effect of Mg with BB was less (OR 0.83, 95% CI 0.60–1.16). Pacing reduced AF (OR 0.60, 95% CI 0.47–0.77, P<0.001), despite wide variations in techniques. Only amiodarone and pacing significantly reduced length of stay, average –0.60 days (95% CI –0.92 to –0.29) and –1.3 days (95% CI –2.55 to –0.08), respectively. Collectively, all treatments analysed together reduced stroke (OR 0.63, 95% CI 0.41–0.98). Amiodarone was the only intervention that alone significantly reduced stroke rate (OR 0.54, 95% CI 0.30–0.95).

Conclusion All five interventions reduced the incidence of AF, though the effect of BBs is less than previously thought. The significant reductions in length of stay and stroke in meta-analysis suggest that there are worthwhile benefits from aggressive prevention. Larger studies to confirm these clinical benefits and evaluate their cost-effectiveness would be worthwhile.

Key Words: Atrial fibrillation • Cardiothoracic surgery • Meta-analysis • Prevention


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

The meta-analysis: supportive or illuminating?
Peter R. Kowey and Gan-Xin Yan
EHJ 2006 27: 2744-2745. [Extract] [FREE Full Text]  



This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
O. J. Liakopoulos, Y.-H. Choi, E. W. Kuhn, T. Wittwer, M. Borys, N. Madershahian, G. Wassmer, and T. Wahlers
Statins for prevention of atrial fibrillation after cardiac surgery: a systematic literature review.
J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 678 - 686.e1.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. Price, R. Tee, B.-K. Lam, P. Hendry, M. S. Green, and F. D. Rubens
Current use of prophylactic strategies for postoperative atrial fibrillation: a survey of Canadian cardiac surgeons.
Ann. Thorac. Surg., July 1, 2009; 88(1): 106 - 110.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
M. A. Crandall, D. J. Bradley, D. L. Packer, and S. J. Asirvatham
Contemporary Management of Atrial Fibrillation: Update on Anticoagulation and Invasive Management Strategies
Mayo Clin. Proc., July 1, 2009; 84(7): 643 - 662.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
R. W Rho
The management of atrial fibrillation after cardiac surgery
Heart, March 1, 2009; 95(5): 422 - 429.
[Full Text] [PDF]


Home page
Eur Heart JHome page
D. Kaireviciute, A. Aidietis, and G. Y.H. Lip
Atrial fibrillation following cardiac surgery: clinical features and preventative strategies
Eur. Heart J., February 2, 2009; 30(4): 410 - 425.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
N. Echahidi, P. Pibarot, G. O'Hara, and P. Mathieu
Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery
J. Am. Coll. Cardiol., February 26, 2008; 51(8): 793 - 801.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. Lertsburapa, C. M. White, J. Kluger, O. Faheem, J. Hammond, and C. I. Coleman
Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery.
J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 405 - 411.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Mariscalco, R. Lorusso, C. Klersy, S. Ferrarese, M. Tozzi, D. Vanoli, B. V. Domenico, and A. Sala
Observational Study on the Beneficial Effect of Preoperative Statins in Reducing Atrial Fibrillation After Coronary Surgery
Ann. Thorac. Surg., October 1, 2007; 84(4): 1158 - 1164.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. E. Kettler, A. Parashar, M. I. Weintraub, A. Khoury, and M. Selim
Perioperative Stroke
N. Engl. J. Med., May 31, 2007; 356(22): 2325 - 2327.
[Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
W. L Baker and C M. White
Post-Cardiothoracic Surgery Atrial Fibrillation: A Review of Preventive Strategies
Ann. Pharmacother., April 1, 2007; 41(4): 587 - 598.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P. R. Kowey and G.-X. Yan
The meta-analysis: supportive or illuminating?
Eur. Heart J., December 1, 2006; 27(23): 2744 - 2745.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.